Hedge Fund - Eversept Partners
Teva Pharmaceutical Industries Ltd (TEVA)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2025 - Q4 (2025-12-31) | $20,604,124 | 1.04% | 660,177 | $24.64 |
| 2 | 2025 - Q3 (2025-09-30) | $27,545,791 | 1.9% | 1,363,653 | $17.56 |
| 3 | 2025 - Q2 (2025-06-30) | $17,646,286 | 1.62% | 1,052,881 | $16.14 |
| 4 | 2025 - Q1 (2025-03-31) | $21,683,458 | 2.2% | 1,410,765 | $17.86 |
| 5 | 2024 - Q4 (2024-12-31) | $49,416,435 | 4.38% | 2,242,125 | $18.19 |
| 6 | 2024 - Q3 (2024-09-30) | $58,288,177 | 3.99% | 3,234,638 | $17.50 |
| 7 | 2024 - Q2 (2024-06-30) | $76,707,475 | 5.25% | 4,720,460 | $15.40 |
| 8 | 2024 - Q1 (2024-03-31) | $85,015,135 | 5.67% | 6,025,169 | $12.61 |
| 9 | 2023 - Q4 (2023-12-31) | $64,251,456 | 5.64% | 6,154,354 | $9.34 |
| 10 | 2023 - Q3 (2023-09-30) | $70,911,267 | 6% | 6,952,085 | $9.31 |
| 11 | 2023 - Q2 (2023-06-30) | $57,740,371 | 4.82% | 7,668,044 | $8.11 |
| 12 | 2023 - Q1 (2023-03-31) | $54,821,962 | 3.82% | 6,194,572 | $9.89 |
| 13 | 2022 - Q4 (2022-12-31) | $42,978,885 | 3.76% | 4,712,597 | $8.73 |
| 14 | 2022 - Q3 (2022-09-30) | $32,787,885 | 2.84% | 4,062,935 | $8.84 |
| 15 | 2022 - Q2 (2022-06-30) | $33,920,479 | 2.41% | 4,510,702 | $8.71 |
| 16 | 2022 - Q1 (2022-03-31) | $38,908,423 | 2.98% | 4,143,602 | $8.35 |
| 17 | 2021 - Q4 (2021-12-31) | $18,434,999 | 1.17% | 2,301,498 | $9.03 |
| 18 | 2021 - Q3 (2021-09-30) | $34,623,791 | 2.39% | 3,554,804 | $9.36 |
| 19 | 2021 - Q2 (2021-06-30) | $37,663,610 | 2.51% | 3,804,405 | $10.58 |
| 20 | 2021 - Q1 (2021-03-31) | $50,253,884 | 3.77% | 4,354,756 | $11.47 |
| 21 | 2020 - Q4 (2020-12-31) | $26,520,613 | 3.11% | 2,748,250 | $9.58 |
| 22 | 2020 - Q3 (2020-09-30) | $21,573,139 | 4.79% | 2,394,355 | $10.58 |
The displayed share prices are average quarterly stock market prices.
Hedge Fund Resource Center